4 results match your criteria: "University of Houston Cullen College of Engineering[Affiliation]"
Comput Chem Eng
January 2025
Department of Chemical and Biomolecular Engineering, University of Houston Cullen College of Engineering, Houston, TX 77204.
Treatment of serious bacterial infections with antimicrobial agents, such as antibiotics, is a major clinical challenge, because of growing bacterial resistance to multiple agents. Combination therapy (i.e.
View Article and Find Full Text PDFCurr Pain Headache Rep
July 2022
Department of Biomedical Engineering, University of Houston Cullen College of Engineering, Houston, TX, USA.
Purpose Of Review: Pain presents a unique challenge due to the complexity of the biological pathways involved in the pain perception, the growing concern regarding the use of opioid analgesics, and the limited availability of optimal treatment options. The use of biomaterials and regenerative medicine in pain management is being actively explored and showing exciting progress in improving the efficacy of conventional pharmacotherapy and as novel non-pharmacological therapy for chronic pain caused by degenerative diseases. In this paper we review current clinical applications, and promising research in the use of biomaterials and regenerative medicine in pain management.
View Article and Find Full Text PDFJ Antimicrob Chemother
January 2021
Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA.
Objectives: Reduced in vitro β-lactam activity against a dense bacterial population is well recognized. It is commonly attributed to the presence of β-lactamase(s) and it is unknown whether the inoculum effect could be diminished by a β-lactamase inhibitor. We evaluated different β-lactam/β-lactamase inhibitor combinations in suppressing a high inoculum of ESBL-producing bacteria.
View Article and Find Full Text PDFJ Law Med Ethics
March 2020
Barbara J. Evans, J.D., Ph.D., LL.M., is Mary Ann and Lawrence E. Faust Professor of Law and Director, Center for Biotechnology & Law, University of Houston Law Center. She is also Professor of Electrical and Computer Engineering, University of Houston Cullen College of Engineering.
Regulatory policy for genomic testing may be subject to biases that favor reliance on existing regulatory frameworks even when those frameworks carry unintended legal consequences or may be poorly tailored to the challenges genomic testing presents. This article explores three examples drawn from genetic privacy regulation, oversight of clinical uses of genomic information, and regulation of genomic software. Overreliance on expedient regulatory approaches has a potential to undercut complete and durable solutions.
View Article and Find Full Text PDF